Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-01

Clinical Trial Update: Topical Sulfasalazine and Oral Lichen Planus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicates that a study evaluating topical sulfasalazine for oral lichen planus is currently active but not recruiting, sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical sulfasalazine (sulfasalazine)

Snippet

Sponsor: Cairo University | Conditions: Oral Lichen Planus, Topical Sulfasalazine | Phase 3 | Status: ACTIVE_NOT_RECRUITING